ETrade Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

ETrade Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,834	Closed	-$651K	–	925
2020 Q1	$651K	Buy	7,834 +402	+5%	+$39.2K	0.02%	399
2019 Q4	$826K	Buy	7,432 +231	+3%	+$23.8K	0.02%	408
2019 Q3	$715K	Buy	7,201 +920	+15%	+$91.4K	0.02%	445
2019 Q2	$623K	Buy	6,281 +1,803	+40%	+$172K	0.02%	485
2019 Q1	$494K	Sell	4,478 -660	-13%	-$69K	0.01%	538
2018 Q4	$472K	Buy	5,138 +1,036	+25%	+$105K	0.02%	497
2018 Q3	$452K	Buy	4,102 +1,355	+49%	+$141K	0.01%	575
2018 Q2	$256K	Buy	+2,747	New	+$237K	0.01%	691
2018 Q1	–	Sell	-2,702	Closed	-$246K	–	787
2017 Q4	$246K	Buy	+2,702	New	+$225K	0.01%	672

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

ETrade Capital Management's PRAH Position: Q2 2020 in Review

ETrade Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 7,834 shares — an estimated $651K sold.

ETrade Capital Management first reported a position in PRAH in Q4 2017 and held it in 9 quarters. The position peaked at $826K in Q4 2019. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

ETrade Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
ETrade Capital Management sold 7,834 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $651K.
ETrade Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 9 quarters.
ETrade Capital Management's PRA Health Sciences, Inc. position peaked at $826K in Q4 2019.
293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on ETrade Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.